FDA Clearance Tracker · P180007-S016
Spiration® Valve System
Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 20, 2026
Approved
Time to decision
16 days
Received Aug 4, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180007-S016
- Device name
- Spiration® Valve System
- Applicant
- Gyrus Acmi, Inc.
- Applicant location
- Redmond, WA
- Received
- Aug 4, 2026
- Decided
- Aug 20, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P180007
Device type
- Device type
- Valve, pulmonary (NJK)
- Device class
- Class III
- Specialty
- Anesthesiology & Respiratory
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P180007.
Source documents
Other decisions for Gyrus Acmi, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252487 · Decided Mar 2, 2026 · 207 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.